Evidence map›Paper›PMID 33029914›Full record

ArticleAddiction (Abingdon, England)2021

Is Cannabis being used as a substitute for non-medical opioids by adults with problem substance use in the United States? A within-person analysis.

Lauren R Gorfinkel, Malki Stohl, Eliana Greenstein, Efrat Aharonovich, Mark Olfson, Deborah Hasin

Open access · greenAbstract read
In one paragraph

Article in Addiction (Abingdon, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Leveraging voice biomarkers to quantify chronic pain: a rapid review.Frontiers in pain research (Lausanne, Switzerland) · 2025
    Review
  7. Article
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Cannabinoid hyperemesis syndrome: the conundrum is here to stay.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lauren R GorfinkelDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.ORCID 0000-0001-5495-4027
Malki StohlNew York State Psychiatric Institute, New York, NY, USA.
Eliana GreensteinNew York State Psychiatric Institute, New York, NY, USA.
Efrat AharonovichDepartment of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY, USA.ORCID 0000-0002-3423-5786
Mark OlfsonDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.ORCID 0000-0002-3958-5662
Deborah HasinDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.ORCID 0000-0002-6533-7021
New York Psychoanalytic Society and Institute · USColumbia University · US

Funding

Phenotypes for Drug Abuse:Epidemiologic-Genetic ApproachR01DA018652 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI HASIN, DEBORAH S · 2004 to 2018
$5.3M
NIDA NIH HHS R01 DA018652
6 · The paper itself

Abstract

BACKGROUND AND

aimsEcological studies have suggested that Cannabis legalization might have led to a decrease in opioid overdose deaths. Such studies do not provide information about whether individuals are substituting Cannabis for opioids at different points in time. The current study assessed the magnitude of the daily association between Cannabis and opioid use in individual adults with and without pain who use non-medical opioids.

designProspective cohort study.

settingThe greater New York area and a suburban inpatient addiction program.

participantsAdults with problem substance use who use non-medical opioids, recruited from May 2016-June 2019. The analytical sample included 13 271 days of observation among 211 participants (64% male, 41% white, 78% unmarried, 80% unemployed, mean age 43 years). MEASUREMENTS: Participants completed interviewer- and self-administered computerized surveys, and then responded to an interactive voice response (IVR) system daily for the following 90 days. The main exposures, Cannabis use and pain, were defined as responding affirmatively to the IVR question: 'Did you use Cannabis yesterday?' and endorsing moderate or severe pain at baseline, respectively. The main outcome, non-medical or illicit opioid use during 90-day follow-up, was defined as responding affirmatively to IVR question: 'Did you use heroin yesterday?' or 'Did you use prescription opioids more than prescribed or without a prescription yesterday?'.

findingsThe mean IVR completion rate was 70%. The unadjusted odds ratio (aOR) indicating same-day use of Cannabis and opioids was 2.00 [95% confidence interval (CI) = 1.54-2.59]. Controlling for demographic characteristics, recruitment method, opioid types at baseline and pain, the aOR was 1.86 (95% CI = 1.44-2.41). A test of interaction between pain and Cannabis use to determine if the association of Cannabis with opioid use differed between people with moderate-to-severe pain and less-than-moderate pain was inconclusive.

conclusionsAmong US adults with problem substance use who use non-medical opioids, the odds of opioid use appear to be approximately doubled on days when Cannabis is used. This relationship does not appear to differ between people with moderate or more severe pain versus less than moderate pain, suggesting that Cannabis is not being used as a substitute for illegal opioids.

Indexed as

CannabisOpioid-Related DisordersAdultAnalgesics, OpioidHumansInfant, NewbornNew YorkProspective StudiesUnited StatesAnalgesics, OpioidCannabismarijuanaopioid epidemicopioid-related disordersopioidspain

Identifiers

PMID33029914
PMCPMC8026758
OpenAlexW3091995004

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.